{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:16Z","timestamp":1792103836945,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04959-3","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:45:45Z","timestamp":1780026345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of metabolic dysfunction-associated steatotic liver disease on non-invasive fibrosis scores in patients with chronic hepatitis B: a multicenter retrospective study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-7313","authenticated-orcid":false,"given":"Yakup","family":"Gezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-264X","authenticated-orcid":false,"given":"Muhammet R\u0131dvan","family":"Tay\u015fi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1245-3221","authenticated-orcid":false,"given":"Arzu","family":"Tarak\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-2477","authenticated-orcid":false,"given":"Sevil","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-2870","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-9198","authenticated-orcid":false,"given":"Zeynep","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Alan Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7624-9286","authenticated-orcid":false,"given":"Emre","family":"Bayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2905-3168","authenticated-orcid":false,"given":"Selcen","family":"\u00d6zer K\u00f6kk\u0131z\u0131l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-7750","authenticated-orcid":false,"given":"Derya","family":"Tumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-4027","authenticated-orcid":false,"given":"Ahmet","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-0239","authenticated-orcid":false,"given":"Tu\u011fba","family":"Demircio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6939-0367","authenticated-orcid":false,"given":"O\u011fuz","family":"Evlice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Basut\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-6013","authenticated-orcid":false,"given":"Zeynep Bur\u00e7in","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-1182","authenticated-orcid":false,"given":"Funda","family":"Memi\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-6361","authenticated-orcid":false,"given":"Ekrem","family":"Salduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3576-0742","authenticated-orcid":false,"given":"Esra","family":"Sa\u011flam Kandemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-0333","authenticated-orcid":false,"given":"Mustafa","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4943-6871","authenticated-orcid":false,"given":"Ethem","family":"\u00d6mero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"4959_CR1","unstructured":"World Health Organization. Global Hepatitis Report 2024. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"issue":"11","key":"4959_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2015.06.028.","journal-title":"Clin Microbiol Infect"},{"key":"4959_CR3","unstructured":"Guideline For The Prevention. Care And Treatment Of Persons With Chronic Hepatitis B Infection. Geneva:2015. World Health Organisation; March 2015."},{"issue":"6","key":"4959_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"8","key":"4959_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"4959_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4254\/wjh.v16.i12.1429","volume":"16","author":"SW Wang","year":"2024","unstructured":"Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, et al. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol. 2024;16(12):1429\u201340. https:\/\/doi.org\/10.4254\/wjh.v16.i12.1429.","journal-title":"World J Hepatol"},{"issue":"10","key":"4959_CR7","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.3390\/jcm14103422","volume":"14","author":"I Hasanoglu","year":"2025","unstructured":"Hasanoglu I, Rivero-Ju\u00e1rez A, \u00d6zkaya \u015eahin G, ESCMID Study Group for Viral Hepatitis (ESGVH). When Metabolic Dysfunction-Associated Steatotic Liver Disease Meets Viral Hepatitis. J Clin Med. 2025;14(10):3422. https:\/\/doi.org\/10.3390\/jcm14103422.","journal-title":"J Clin Med"},{"issue":"4","key":"4959_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s10620-024-08354-4","volume":"69","author":"D Con","year":"2024","unstructured":"Con D, Tu S, Clayton-Chubb D, Lubel JS, Nicoll AJ, Sawhney R, et al. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Dig Dis Sci. 2024;69(4):1496\u2013506. https:\/\/doi.org\/10.1007\/s10620-024-08354-4.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4959_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, et al. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Curr Obes Rep. 2024;13(3):510\u201331. https:\/\/doi.org\/10.1007\/s13679-024-00574-z.","journal-title":"Curr Obes Rep"},{"issue":"6","key":"4959_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6.","journal-title":"J Hepatol"},{"issue":"2","key":"4959_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"M Cornberg","year":"2025","unstructured":"Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, et al. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83(2):502\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.018.","journal-title":"J Hepatol"},{"issue":"5","key":"4959_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2024.11.049","volume":"82","author":"P Cal\u00e8s","year":"2025","unstructured":"Cal\u00e8s P, Canivet CM, Costentin C, Lannes A, Oberti F, Fouchard I, et al. A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD. J Hepatol. 2025;82(5):794\u2013804. https:\/\/doi.org\/10.1016\/j.jhep.2024.11.049.","journal-title":"J Hepatol"},{"issue":"2","key":"4959_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C. Hepatology. 2003;38(2):518\u201326. https:\/\/doi.org\/10.1053\/jhep.2003.50346.","journal-title":"Hepatology"},{"issue":"1","key":"4959_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u20136. https:\/\/doi.org\/10.1002\/hep.21669.","journal-title":"Hepatology"},{"issue":"3","key":"4959_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.hepres.2005.12.004","volume":"34","author":"A Attallah","year":"2006","unstructured":"Attallah A, Shiha G, Omran M, Zalata K. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and\/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol Res. 2006;34(3):163\u20139. https:\/\/doi.org\/10.1016\/j.hepres.2005.12.004.","journal-title":"Hepatol Res"},{"issue":"3","key":"4959_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/sjg.sjg_27_24","volume":"30","author":"K Alswat","year":"2024","unstructured":"Alswat K, Soliman R, Mikhail NNH, \u00d6rmeci N, Dalekos GN, Derbala MFM, et al. Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B. Saudi J Gastroenterol. 2024;30(3):138\u201344. https:\/\/doi.org\/10.4103\/sjg.sjg_27_24.","journal-title":"Saudi J Gastroenterol"},{"issue":"1","key":"4959_CR17","doi-asserted-by":"publisher","first-page":"100544","DOI":"10.1016\/j.aohep.2021.100544","volume":"27","author":"S Okdemir","year":"2022","unstructured":"Okdemir S, Cakmak E. A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B. Ann Hepatol. 2022;27(1):100544. https:\/\/doi.org\/10.1016\/j.aohep.2021.100544.","journal-title":"Ann Hepatol"},{"issue":"8","key":"4959_CR18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016;65(8):1369\u201376. https:\/\/doi.org\/10.1136\/gutjnl-2015-309260.","journal-title":"Gut"},{"issue":"7","key":"4959_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/MEG.0b013e32830dfcb3","volume":"21","author":"TJS Cross","year":"2009","unstructured":"Cross TJS, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King\u02bcs Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21(7):730\u20138. https:\/\/doi.org\/10.1097\/MEG.0b013e32830dfcb3.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"4959_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/00365520510015674","volume":"40","author":"S Islam","year":"2005","unstructured":"Islam S, Antonsson L, Westin J, Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol. 2005;40(7):867\u201372. https:\/\/doi.org\/10.1080\/00365520510015674.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"4959_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1440-1746.2010.06383.x","volume":"25","author":"K Zhou","year":"2010","unstructured":"Zhou K, Gao C, Zhao Y, Liu H, Zheng R, Xian J, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25(9):1569\u201377. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06383.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4959_CR22","first-page":"614","volume":"32","author":"YY Hsieh","year":"2009","unstructured":"Hsieh YY, Tung SY, Lee IL, Lee K, Shen CH, Wei KL, et al. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J. 2009;32(6):614\u201322. PubMed PMID: 20035640.","journal-title":"Chang Gung Med J"},{"issue":"1","key":"4959_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-230X-11-44","volume":"11","author":"W Ahmad","year":"2011","unstructured":"Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, et al. A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011;11(1):44. https:\/\/doi.org\/10.1186\/1471-230X-11-44.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"4959_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2893.1997.00141.x","volume":"4","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat. 1997;4(3):199\u2013208. https:\/\/doi.org\/10.1046\/j.1365-2893.1997.00141.x.","journal-title":"J Viral Hepat"},{"key":"4959_CR25","doi-asserted-by":"publisher","DOI":"10.14744\/hf.2020.2020.0027","author":"H Yarkan Tu\u011fsal","year":"2020","unstructured":"Yarkan Tu\u011fsal H. ATA Index: A Novel Score for Predicting Fibrosis Stage in Chronic Viral Hepatitis. Hepatol Forum. 2020. https:\/\/doi.org\/10.14744\/hf.2020.2020.0027.","journal-title":"Hepatol Forum"},{"key":"4959_CR26","doi-asserted-by":"publisher","unstructured":"Ohta T, Sakaguchi K, Fujiwara A, Fujioka S, ichi, Iwasaki Y, Makino Y et al. Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. [Internet]. Okayama University Medical School; 2006. Available from: https:\/\/doi.org\/10.18926\/AMO\/30729. Cited 2026 Apr 18.","DOI":"10.18926\/AMO\/30729"},{"issue":"2","key":"4959_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ajg.2011.04.006","volume":"12","author":"MM Omran","year":"2011","unstructured":"Omran MM, Farid K, Emran TM, Attallah AA. Fibro-\u03b1 score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol. 2011;12(2):74\u20139. https:\/\/doi.org\/10.1016\/j.ajg.2011.04.006.","journal-title":"Arab J Gastroenterol"},{"issue":"10","key":"4959_CR28","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1478-3231.2008.01784.x","volume":"28","author":"J Fung","year":"2008","unstructured":"Fung J, Lai C, Fong DY, Yuen JC, Wong DK, Yuen M. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver Int. 2008;28(10):1408\u201316. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01784.x.","journal-title":"Liver Int"},{"issue":"2","key":"4959_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.20772","volume":"42","author":"ASF Lok","year":"2005","unstructured":"Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort\u2020. Hepatology. 2005;42(2):282\u201392. https:\/\/doi.org\/10.1002\/hep.20772.","journal-title":"Hepatology"},{"issue":"4","key":"4959_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD\u2020. Hepatology. 2007;45(4):846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatology"},{"issue":"3","key":"4959_CR31","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/liv.70042","volume":"45","author":"LA Patmore","year":"2025","unstructured":"Patmore LA, Van Eekhout K, Koc \u00d6M, De Knegt RJ, Janssen HLA, Brouwer WP, et al. The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B. Liver Int. 2025;45(3):e70042. https:\/\/doi.org\/10.1111\/liv.70042.","journal-title":"Liver Int"},{"issue":"2","key":"4959_CR32","doi-asserted-by":"publisher","first-page":"101589","DOI":"10.1016\/j.aohep.2024.101589","volume":"30","author":"S Hong","year":"2025","unstructured":"Hong S, Hao Y, Sun L, Li P, Yang J, Zhang F, et al. Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease. Ann Hepatol. 2025;30(2):101589. https:\/\/doi.org\/10.1016\/j.aohep.2024.101589.","journal-title":"Ann Hepatol"},{"key":"4959_CR33","doi-asserted-by":"publisher","unstructured":"Seto WK, Lai CL, Ip PPC, Fung J, Wong DKH, Yuen JCH et al. A Large Population Histology Study Showing the Lack of Association between ALT Elevation and Significant Fibrosis in Chronic Hepatitis B. Lo AWI, editor. PLoS ONE. 2012;7(2):e32622. https:\/\/doi.org\/10.1371\/journal.pone.0032622.","DOI":"10.1371\/journal.pone.0032622"},{"issue":"6","key":"4959_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/jmv.22048","volume":"83","author":"T G\u00f6bel","year":"2011","unstructured":"G\u00f6bel T, Erhardt A, Herwig M, Poremba C, Baldus SE, Sagir A, et al. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe. J Med Virol. 2011;83(6):968\u201373. https:\/\/doi.org\/10.1002\/jmv.22048.","journal-title":"J Med Virol"},{"issue":"4","key":"4959_CR35","doi-asserted-by":"publisher","first-page":"2149641","DOI":"10.1002\/eji.202149641","volume":"54","author":"K Mladeni\u0107","year":"2024","unstructured":"Mladeni\u0107 K, Lenarti\u0107 M, Marinovi\u0107 S, Poli\u0107 B, Wensveen FM. The Domino effect in MASLD: The inflammatory cascade of steatohepatitis. Eur J Immunol. 2024;54(4):2149641. https:\/\/doi.org\/10.1002\/eji.202149641.","journal-title":"Eur J Immunol"},{"key":"4959_CR36","doi-asserted-by":"publisher","unstructured":"Liu Y, rui, Lin, bin B, Zeng, wu D, Zhu Y, yong, Chen, J, Zheng, Q, et al. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. BMC Gastroenterol. 2014;14(1):145. https:\/\/doi.org\/10.1186\/1471-230X-14-145.","DOI":"10.1186\/1471-230X-14-145"},{"issue":"5","key":"4959_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/medicina59050923","volume":"59","author":"K Yang","year":"2023","unstructured":"Yang K, Pan Y, Liu L, Sun B, Shi W. Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients. Med (Mex). 2023;59(5):923. https:\/\/doi.org\/10.3390\/medicina59050923.","journal-title":"Med (Mex)"},{"issue":"1","key":"4959_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12879-024-10408-x","volume":"25","author":"T Xing","year":"2025","unstructured":"Xing T. Existing problems and new advice on stage criteria of natural history for chronic hepatitis B. BMC Infect Dis. 2025;25(1):17. https:\/\/doi.org\/10.1186\/s12879-024-10408-x.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4959_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3350\/cmh.2014.20.3.228","volume":"20","author":"GLH Wong","year":"2014","unstructured":"Wong GLH. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol. 2014;20(3):228. https:\/\/doi.org\/10.3350\/cmh.2014.20.3.228.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"4959_CR40","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.12787","volume":"35","author":"M Lapalus","year":"2015","unstructured":"Lapalus M, Laouenan C, Cardoso A, Estrabaud E, Carvalho-Filho RJ, Zhang Q, et al. Precore\/Core promoter variants to predict significant fibrosis in both HB eAg positive and negative chronic hepatitis B. Liver Int. 2015;35(9):2082\u20139. https:\/\/doi.org\/10.1111\/liv.12787.","journal-title":"Liver Int"},{"issue":"1","key":"4959_CR41","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.aohep.2023.101155","volume":"29","author":"R Yao","year":"2024","unstructured":"Yao R, Lu S, Xue R, Wang J, Qiu Y, Chen Y, et al. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study. Ann Hepatol. 2024;29(1):101155. https:\/\/doi.org\/10.1016\/j.aohep.2023.101155.","journal-title":"Ann Hepatol"},{"issue":"5","key":"4959_CR42","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/liv.15541","volume":"43","author":"KW Lin","year":"2023","unstructured":"Lin KW, Kumar R, Shen F, Chan HL-Y, Wong GL\u2010H, Kumar R, et al. The utility of non\u2010invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis. Liver Int. 2023;43(5):1008\u201314. https:\/\/doi.org\/10.1111\/liv.15541.","journal-title":"Liver Int"},{"issue":"4","key":"4959_CR43","doi-asserted-by":"publisher","first-page":"e29613","DOI":"10.1002\/jmv.29613","volume":"96","author":"L Chen","year":"2024","unstructured":"Chen L, Tao X, Zeng M, Li Y, Han J, Wang Y, et al. Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease. J Med Virol. 2024;96(4):e29613. https:\/\/doi.org\/10.1002\/jmv.29613.","journal-title":"J Med Virol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04959-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:20:39Z","timestamp":1782976839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04959-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4959"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04959-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Non-Interventional Clinical Research Ethics Committee of Konya City Hospital, University of Health Sciences (Approval No: 2025\/44 \u2013 dated 10.03.2025). The Ethics Committee of Konya City Hospital, University of Health Sciences waived the requirement for participant consent due to the retrospective nature of the study and the use of anonymized data. As part of the consent process, general consent was obtained for the use of medical records in research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}